and so far covax is way behind on its targets, you know, it is about 190 million doses short of where it was hoping to be by the end ofjune, and it is kind of been outmanoeuvred and outbid by wealthy countries that have locked up vaccine supplies with deals with the most promising vaccine developers. but the reality is there is — the us in particular, i would say, is in a position to be sharing more doses than it is, you know, and at the current rate it is going, i think it is delivering about 70 million doses more than has been administered, so they are really looking at a glut in vaccine supply and, you know, i think rich countries should be realising it is in their self—interest now to be sharing those vaccines more widely in order to contain the virus, as well as slow the spread of these variants that are developing and seem to be boomeranging back into rich countries.